Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT00482690Not ApplicableTerminated

Analysis of Aldehyde Biomarkers of Exposure and Host Response

Role: collaborator

NCT02185898Not ApplicableCompleted

Evaluation of Environmental Emissions From Electronic Cigarettes and Tobacco-Burning Cigarettes

Role: collaborator

NCT01923402Completed

Development of Biomarkers of Effect From Chronic Tobacco Usage

Role: lead

NCT02061917Not ApplicableCompleted

Switching From Usual Brand Cigarettes to a Tobacco-heating Cigarette or Snus

Role: lead

NCT01692353Completed

Cardiovascular Disease Biomarkers in Smokers and Moist Snuff Consumers

Role: lead

All 5 trials loaded